Clinical trial
Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients
NCT00481637 · Rockefeller University, Other · Completed
Key facts
| NCT number | NCT00481637 |
|---|---|
| Title | Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients |
| Official title | Tumor Immunity in Neurologically Normal Patients |
| Lead sponsor | Rockefeller University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Cancer |
| Enrollment | 33 |
| Start date | Mar 1, 1998 |
| Primary completion | May 1, 2013 |
| Completion | May 1, 2013 |
| First posted | Jun 4, 2007 |
| Last update posted | Apr 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: